MedicineWorld.Org
Your gateway to the world of medicine
Home
News
Cancer News
About Us
Cancer
Health Professionals
Patients and public
Contact Us
Disclaimer



MedicineWorld.Org - Cancer - Adjuvant Tamoxifen (Nolvadex) treatment for DCIS
Your gateway to information on adjuvant tamoxifen (nolvadex) treatment for dcis

MedicineWorld.Org: Adjuvant Tamoxifen (Nolvadex) treatment for DCIS

Adjuvant Tamoxifen (Nolvadex) treatment for DCIS   

             arcgba.gif
       Adjuvant therapy is not routinely advised for patients with ductal carcinoma in situ. However Tamoxifen has been shown to decrease the risk of secondary breast cancer in women with high risk of breast cancer including women with history of ductal carcinoma in situ. Some physicians routinely recommend treatment with Tamoxifen in all patients who have been diagnosed with ductal carcinoma in situ. In the NSABP trial adjuvant use of Tamoxifen has shown to decrease the breast cancer recurrence risk in patients with ductal carcinoma in situ has been shown to decrease form 13.4% to 8.2% with the use of adjuvant tamoxifen.   Tamoxifen decreases the risk of breast cancer in the involved breast as well as in the contra-lateral breast. Based on these observations, Tamoxifen may be considered as an adjuvant therapy in women with ductal carcinoma in situ. The role of Tamoxifen or other hormonal drugs in the treatment of ductal carcinoma in situ will become clearer over the next few years. For more information on hormonal therapy of breast cancer please refer to section on hormonal therapy of breast cancer.

Hormonal therapy
 


Adjuvant Tamoxifen (Nolvadex) treatment for DCIS

 
BREAST CANCER MAIN PAGE
Home| Breast cancer news | Common terms| Breast cancer treatment| Treatment by stage| Surgical treatment| Chemotherapy| Chemo drugs| Breast cancer symptoms| Mammogram and breast cancer screening| Doxorubicin| Cyclophosphamide| Methotrexate| Hormonal therapy| Radiation therapy| Monoclonal therapy| High dose chemotherapy| Recurrent breast cancer| Bisphosphonates | Pregnancy and breast cancer | Risk factors | Risk details | My risk | Comprehensive | Breast cancer statistics | African Americans | Ashkenazi | Asians | Hispanic | Men | Native Americans | Older women | Younger women | Pregnant women | BRCA
 


Copyright statement
The contents of this web page are protected. Legal action may follow for reproduction of materials without permission.